To the Editor,I have read, with great interest, the article entitled "Influence of Smoking Consumption
and Nicotine Dependence Degree in Cardiac Autonomic Modulation" by Santos et
al.,[1] recently published in
Arquivos Brasileiros de Cardiologia 2016; 106: 510-8. The reseearchers reported that
only the intensity of smoking consumption had influences over cardiac autonomic
modulation of the evaluated smokers. Smokers with severe smoking consumption intensity
presented worse autonomic modulation than moderate ones.[1]Antidepressant medications are a first-line treatment option for moderate to severe mood
and anxiety disorders; however, some studies suggest that long-term use may be
associated with an increased risk for cardiovascular disease.[2-4]Kemp et al.[5] reported that all users of
selective serotonin reuptake inhibitor - except fluoxetine - display alterations in
heart rate or heart rate variability (HRV) in comparison to non users. Similarly, users
of paroxetine also display small to moderate reductions in HRV relative to users of
citalopram, fluoxetine, and sertraline, but not escitalopram.In this context, it might be beneficial to give more details about medications due to
their effect on cardiac autonomic activity.Firstly, I would like to thank you for your interest in our manuscript entitled
"Influence of Smoking Consumption and Nicotine Dependence Degree in Cardiac
Autonomic Modulation" by Santos APS et al., recently published in this magazine.As described in the Methods section of the study, individuals on medications that
influence cardiac autonomic modulation were not included. Antidepressants, which are
among said medications, are commonly used by smokers, sometimes as a part of a drug
therapy to aid in the cessation of the smoking habit.Even though participants of the study were part of an Antismoking Awareness and
Orientation Program, which consists of the association of cognitive behavioral and
drug therapy, they had not yet started the offered treatment, and the cardiac
autonomic modulation evaluation was done with smokers who were not abstinent or on
specific cessation medication.Given the above, we can state that, in our study, there was no influence of
medications that could alter cardiac autonomic modulation.
Authors: Jordan W Smoller; Matthew Allison; Barbara B Cochrane; J David Curb; Roy H Perlis; Jennifer G Robinson; Milagros C Rosal; Nanette K Wenger; Sylvia Wassertheil-Smoller Journal: Arch Intern Med Date: 2009-12-14
Authors: Andrew H Kemp; Renerio Fráguas; Andre R Brunoni; Marcio S Bittencourt; Maria A Nunes; Eduardo M Dantas; Rodrigo V Andreão; José G Mill; Antonio L P Ribeiro; Julian Koenig; Julian F Thayer; Isabela M Benseñor; Paulo A Lotufo Journal: Psychosom Med Date: 2016-09 Impact factor: 4.312
Authors: William Whang; Laura D Kubzansky; Ichiro Kawachi; Kathryn M Rexrode; Candyce H Kroenke; Robert J Glynn; Hasan Garan; Christine M Albert Journal: J Am Coll Cardiol Date: 2009-03-17 Impact factor: 27.203
Authors: Ana Paula Soares Dos Santos; Dionei Ramos; Gabriela Martins de Oliveira; Ana Alice Soares Dos Santos; Ana Paula Coelho Figueira Freire; Juliana Tiyaki Ito; Renato Peretti Prieto Fernandes; Luiz Carlos Marques Vanderlei; Ercy Mara Cipulo Ramos Journal: Arq Bras Cardiol Date: 2016-05-03 Impact factor: 2.000